CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Digipath Inc Company Snapshot
Digipath Inc operates in the Testing laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Digipath Inc with three other miscellaneous service companies in North America: Northwest Biotherapeutics, Inc. (2019 sales of $2.41 million ), Eyegate Pharmaceuticals Inc ($2.69 million of which 100% was Eyecare products), and Xeris Pharmaceuticals Inc ($2.72 million of which 100% was Commercial physical).

Sales Analysis. Digipath Inc reported sales of $2.55 million for the fiscal year ending September of 2019. This represents a decrease of 10.1% versus 2018, when the company's sales were $2.84 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Digipath Inc
  Stock Performance Chart for Digipath Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): .03
(Figures in U.S. Dollars)
1 Week -5.0%   13 Weeks -0.6%  
4 Weeks -35.4%   52 Weeks -78.5%  
 
Digipath Inc Key Data:
  Ticker: DIGP Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Testing Laboratories
  2019 Sales 2,552,600
(Year Ending Jan 2020).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 1,489,288
  Fiscal Yr Ends: September Shares Outstanding: 57,612,672
  Share Type: Common Closely Held Shares: 8,853,285
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.